Evidence map›Paper›PMID 39673773›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Changes in Thyroid Function and Autoimmunity in Older Individuals: Longitudinal Analysis of the Whickham Cohort.

Salman S Razvi, Helen Wild, Lorna Ingoe, Jonathan Vernazza, Mark Vanderpump, Simon H S Pearce, Marian Ludgate

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Salman S RazviTranslational and Clinical Research Institute, Newcastle University Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK.ORCID 0000-0002-9047-1556
Helen WildDepartment of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead NE9 6SX, UK.
Lorna IngoeDepartment of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead NE9 6SX, UK.
Jonathan VernazzaDepartment of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead NE9 6SX, UK.
Mark VanderpumpOneWelbeck Endocrinology, 1 Wellbeck Street, London W1G 0AR, UK.
Simon H S PearceTranslational and Clinical Research Institute, Newcastle University Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK.
Marian LudgateThyroid Research Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

Funding

British Thyroid FoundationMedical Research Council G0500783Medical Research Council MR/V005898/1
6 · The paper itself

Abstract

backgroundLongitudinal studies of thyroid function have demonstrated differing results. It remains unclear whether changes in thyroid function affect the diagnosis of subclinical thyroid dysfunction with aging.

methodsSurvivors of the Whickham cohort study were evaluated on 2 occasions between the years 2008 and 2012 and 2016 and 2019. Serum TSH, free T4 (FT4), free T3 (FT3), and thyroid peroxidase antibody (TPOAb) were measured on both occasions using the same assay under similar conditions. Individuals with known thyroid disease or on medications affecting thyroid function were excluded. Comorbidities were noted, functional mobility was assessed by the timed up-and-go test, and muscle function was evaluated by the hand grip strength test.

resultsIn 204 individuals (mean age 77.0 [±6.6] years, 114 [56%] female), followed over a median (interquartile range) of 7.8 (7.3-8.2) years, serum TSH increased by 0.29 mU/L (12.4%), FT3 and TPOAb reduced by 0.1 pmol/L (-2.1%) and 0.6 U/L (-11.2%), and there were no significant changes in FT4 levels. The calculated upper limit of serum TSH increased over the follow-up period from 4.74 mU/L to 6.28 mU/L. The relationship between serum TSH and FT4 at both time points was not significantly different. Utilizing standard laboratory reference ranges, the prevalence of subclinical hypothyroidism increased from 3.5% at baseline to 9.0% at follow-up. However, adopting a visit-specific TSH reference range reduced the prevalence of subclinical hypothyroidism at both time points to 2.0%. DISCUSSION: Thyroid function demonstrates subtle but significant changes with age. Utilizing standard reference ranges tends to increase the diagnosis of subclinical hypothyroidism in older euthyroid individuals. Our data suggest that adopting age-appropriate TSH reference ranges may reduce the risk of diagnosing and (potentially unnecessarily) treating subclinical hypothyroidism.

Indexed as

AgingAutoimmunityThyroid DiseasesThyroid GlandThyroid HormonesAgedAged, 80 and overDiagnosis, DifferentialFemaleFollow-Up StudiesGeriatric AssessmentHumansHypothyroidismLongitudinal StudiesMalePrevalenceThyroid Hormonesagingthyroid functionTSH

Identifiers

PMID39673773
PMCPMC12342363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.